Correlation Between Legend Biotech and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Legend Biotech and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Legend Biotech and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Legend Biotech Corp and Agios Pharm, you can compare the effects of market volatilities on Legend Biotech and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Legend Biotech with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Legend Biotech and Agios Pharm.
Diversification Opportunities for Legend Biotech and Agios Pharm
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Legend and Agios is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Legend Biotech Corp and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Legend Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Legend Biotech Corp are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Legend Biotech i.e., Legend Biotech and Agios Pharm go up and down completely randomly.
Pair Corralation between Legend Biotech and Agios Pharm
Given the investment horizon of 90 days Legend Biotech Corp is expected to generate 1.24 times more return on investment than Agios Pharm. However, Legend Biotech is 1.24 times more volatile than Agios Pharm. It trades about 0.06 of its potential returns per unit of risk. Agios Pharm is currently generating about -0.03 per unit of risk. If you would invest 3,277 in Legend Biotech Corp on December 28, 2024 and sell it today you would earn a total of 262.00 from holding Legend Biotech Corp or generate 8.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Legend Biotech Corp vs. Agios Pharm
Performance |
Timeline |
Legend Biotech Corp |
Agios Pharm |
Legend Biotech and Agios Pharm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Legend Biotech and Agios Pharm
The main advantage of trading using opposite Legend Biotech and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Legend Biotech position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.Legend Biotech vs. Vaxcyte | Legend Biotech vs. Apellis Pharmaceuticals | Legend Biotech vs. Travere Therapeutics | Legend Biotech vs. Akero Therapeutics |
Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |